HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retroperitoneoscopic pancreatectomy: a new surgical option for pancreatic disease.

AbstractOBJECTIVE:
The advantage of retroperitoneoscopy in renal and adrenal gland surgery has been widely acknowledged. Retroperitoneoscopy may also be a useful approach to the pancreas, a retroperitoneal organ. This study aims to evaluate the feasibility of retroperitoneoscopic pancreatectomy performed in an animal model and a small patient cohort.
METHODS:
This study was divided into two stages. Initially, retroperitoneoscopic distal pancreatectomy was performed in 6-month-old Yorkshire breed piglets (n = 5; mean weight, 50 ± 5 kg). Subsequently, seven patients with suspected diagnosis of distal pancreatic lesions were selected between February 2010 and April 2011 to undergo retroperitoneoscopy. Approval was obtained from both the Animal Ethics Committee and the Institutional Review Board.
RESULTS:
In the animal models, retroperitoneoscopic procedures were accomplished smoothly with short operative time, insignificant blood loss, and only minor complications. In clinical practice, patients with histologically confirmed pancreatic diseases underwent enucleation (n = 2) or distal pancreatectomy with splenic preservation (n = 2). Operative times ranged from 30 to 100 min with controllable blood loss of 10-100 ml. One case of intraoperative retroperitoneal perforation and two cases of pancreatic fistula occurred. All four patients were discharged within 7 days postoperatively. The other three patients with nonpancreatic diseases underwent retroperitoneoscopic resection with excellent clinical outcome.
CONCLUSIONS:
The results of this preliminary study demonstrate that retroperitoneoscopic pancreatectomy, a novel surgical approach, was feasible and effective in selected patients. The advantages of this approach include acceptable operating time, insignificant blood loss, simple manipulations, minor complications, and excellent postoperative recovery time. Additionally, this study suggests that retroperitoneoscopy could also be feasible for treatment of retroperitoneal nonpancreatic diseases.
AuthorsGuodong Zhao, Ruihua Xue, Xin Ma, Minggen Hu, Xinjin Gu, Baofu Wang, Xu Zhang, Rong Liu
JournalSurgical endoscopy (Surg Endosc) Vol. 26 Issue 6 Pg. 1609-16 (Jun 2012) ISSN: 1432-2218 [Electronic] Germany
PMID22179465 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adult
  • Animals
  • Blood Loss, Surgical (statistics & numerical data)
  • Feasibility Studies
  • Female
  • Humans
  • Laparoscopy (methods)
  • Male
  • Middle Aged
  • Pancreatectomy (methods)
  • Pancreatic Diseases (surgery)
  • Postoperative Complications (etiology)
  • Retroperitoneal Space
  • Sus scrofa
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: